Valeant Rivals’ Stocks Suffer. wsj The worries about Valeant Pharmaceuticals International Inc.’s prospects are spreading beyond the company’s stock and crushing shares of other specialty pharmaceutical firms.The companies that are getting hit the worst this week are ones that investors see as following a playbook similar to Valeant, though the companies generally maintain otherwise.